Skip to main content
. 2011 Nov;18(11):1900–1907. doi: 10.1128/CVI.05312-11

Table 1.

Specificity and sensitivity of the MAb-based serotyping assay

MAb no. MAb designation Serotype specificitya IC50 (ng/ml)b
1 Hyp1G4 1 8
2 Hyp2M2 2 10
3 Hyp3M6 3 6
4 Hyp4M3 4 6
5 Hyp5M3 5 12
6 Hyp6AM3 6A 3
7 Hyp6BM1 6B 77
8 Hyp6DM5 6C/6D 14
9 Hyp7FM15 7F/7A 52
10 Hyp8M2 8 10
11 Hyp9NM3 9N 8
12 Hyp9VM7 9V/9A 1
13 Hyp10AG3 10A/39 58
14 Hyp11AM2 11A/11D/11F 13
15 Hyp11AM1 11E/(11A/11D/11F) 15
16 Hyp12FM3 12F 26
17 Hyp14M11 14 5
18 Hyp15BG5 15B/(15C) 68
19 Hyp17FM6 17F/17A 6
20 Hyp18CM1 18C 5
21 Hyp19AG1 19A 5
22 Hyp19FM3 19F 5
23 Hyp20G5 20 29
24 Hyp22FM2 22F/22A 4
25 Hyp23FG3 23F 16
26 Hyp33FG1 33F/33A 18
a

Serotypes in parentheses are those with partial cross-reaction. Hyp10AG3 does not cross-react with 10B, unlike Danish factor serum 10d (12).

b

The PS concentration required to inhibit 50% of MAb binding to the enzyme-linked immunosorbent assay plate.